4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
11.99
+0.34 (2.92%)
Aug 14, 2026, 3:44 PM EDT - Market open
4D Molecular Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 14, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $35 | Buy | Reiterates | $35 | +191.91% | Aug 14, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $36 | Buy | Reiterates | $36 | +200.25% | Aug 14, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 14, 2026 |
Unknown Analyst B. Riley Securities No rating | B. Riley Securities | Buy Initiates $37 | Buy | Initiates | $37 | +208.59% | Jul 31, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $23 | Buy | Maintains | $23 | +91.83% | Jul 20, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $33 | Buy | Maintains | $33 | +175.23% | Jul 20, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.